EFFECT OF LITHIUM AND SODIUM-IONS ON OPIATE-RECEPTOR AND DOPAMINE-RECEPTOR BINDING

被引：25

作者：

WAJDA, IJ

BANAYSCHWARTZ, M

MANIGAULT, I

LAJTHA, A

机构：

来源：

NEUROCHEMICAL RESEARCH | 1981年 / 6卷 / 03期

关键词：

D O I：

10.1007/BF00964047

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：321 / 331

页数：11

共 20 条

[1]

CAROL BJ, 1972, J PHARMACOL, V46, P124

[2] PHARMACOKINETICS OF LITHIUM AND ITS REGIONAL DISTRIBUTION IN RAT-BRAIN [J].

EBADI, MS ;

SIMMONS, VJ ;

HENDRICKSON, MJ ;

LACY, PS .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 27 (03) :324-329

[3]

EBSTEIN RP, 1980, BIOL PSYCHIAT, V15, P459

[4]

KLINE NS, 1979, LITHIUM CONTROVERSIE, P122

[5]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[6] REGIONAL ALTERATIONS IN RAT-BRAIN NEUROTRANSMITTER SYSTEMS FOLLOWING CHRONIC LITHIUM TREATMENT [J].

MAGGI, A ;

ENNA, SJ .

JOURNAL OF NEUROCHEMISTRY, 1980, 34 (04) :888-892

[7]

NELSON SC, 1980, J PHARMACOL EXP THER, V212, P11

[8]

PASTERNAK GW, 1974, MOL PHARMACOL, V10, P183

[9] LONG-TERM TREATMENT WITH LITHIUM PREVENTS DEVELOPMENT OF DOPAMINE RECEPTOR SUPER-SENSITIVITY [J].

PERT, A ;

ROSENBLATT, JE ;

SIVIT, C ;

PERT, CB ;

BUNNEY, WE .

SCIENCE, 1978, 201 (4351) :171-173

[10]

PERT CB, 1974, MOL PHARMACOL, V10, P868

← 1 2 →